Soridol (Psoriasis Cream)

Psoriasis is an autoimmune inflammatory disease that originates from numerous, diverse causes. Ultimately, inflammation is to blame for physical symptoms of extremely dry, red and itchy skin. Psoriasis can cause traumatic physical and psychological effects in its sufferers, which is why its origins are important to pin down. The triggers initiating psoriasis are many, including genetic predisposition. Furthermore, infections and diseases of the liver and the kidneys can incite a psoriatic reaction. Even environmental and emotional stressors have been linked to psoriasis. It is, in fact, difficult for scientists to ascertain the differences between its causes and symptoms. The unique liposomal formulation, boosted by hemp extracts with high amounts of CBD, allows ingredients to penetrate deep into the skin, where they are needed most. The formula’s careful balance of ingredients calms the itch and keeps skin hydrated, protected, and nourished with crucial vitamins and antioxidants. This improves the skin’s structural and defence systems, restoring the pathological pathways that trigger symptoms of psoriasis.



In the case of psoriasis, skin is harder to rejuvenate since its many layers are excessively dry and flaky. Soridol’s formula contains liposomes-small vesicles that transfer active ingredients directly to cells, into the areas that need them most. It allows psoriasis sufferers to receive heightened benefits than they would with some other skin products. At Cibdol, we do things other CBD manufacturers don’t. Our years of experience manufacturing high-quality Forest Green CBD wellness products have put us ahead of the pack in developing proprietary procedures to create the most naturally potent and effective CBD supplements. Using 100% organic raw materials and clean cannabinoid extraction methods, we are constantly looking to better our business and discover new ways to channel the power of CBD. Those allergic to any of the product ingredients (see ingredients section for detailed information), especially those allergic to grasses (Poaceae) should avoid the use of Soridol. Gluten and/or soy intolerant individuals should consult their personal healthcare provider prior to use. Oatmeal contains gluten, and lecithin is made from soy.



After clearing its way through EU-GMP certification, a North Macedonian company is now able to export medical cannabis products to the EU. How will this affect the landscape of medical cannabis in Europe? In Macedonia, cannabis is not legal for recreational use at all, and there are no decriminalization or personal use laws to boot. However, in 2016, Macedonia did approve a bill for medical cannabis within the country. As per Macedonian laws, which sync with EU laws here, oils and extracts can have up to .2% THC and still be sold without a prescription. Cannabis with any higher THC amount can be obtained through prescription. The laws allow for private citizens to make use of medical cannabis, as well as for Macedonia to enter into the legal medical cannabis market with laws to cover cultivation, production, and exportation for medicinal use. Since that time, and according to internal legislation, Macedonia has been exporting extracts, oils, and tinctures, but that’s it.



And while that does account for about 30% of the market, the great majority - 70% - relies on smokable hemp flowers, which Macedonia had not been cleared to export at all. Until now though, the EU was not included in exportable locations for any goods as no companies had EU-GMP authorization. What’s the biggest problem? One of the biggest issues for Macedonia is that cannabis flowers have not been legalized for exportation. A big factor in this inability comes from internal licensing issues that stem from allegations of corruption. The allegations centered around former Prime Minister Zoran Zaev showing preferential treatment when giving out licenses, opting to give them to friends and family members which would, in turn, benefit him personally. There were also a lot of questions and calls for specifications relating to how licensing would generally work, issues related to the program being government run, and opposition to the €500 bank guarantee that many thought would make it harder for smaller enterprises to gain ground.